Bristol Myers Squibb, US1101221083

Bristol Myers Squibb stock trades at EUR 53.13 with USD 121.5 billion market cap

Published on 10/08/2026 at 20:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bristol Myers Squibb stock stood at EUR 53.13 on October 8, 2026 versus EUR 53.44. Third-quarter results are due October 29, 2026, and P/E is 13.1.

Key points in brief

  • Bristol Myers Squibb stock was trading at EUR 53.13 at Lang & Schwarz on October 8, 2026, minus 0.58 percent versus EUR 53.44.
  • The company had a USD 121.5 billion market capitalization and a P/E ratio of 13.10 on October 8, 2026.
  • The NYSE quotation stood at USD 59.49, 13.33 percent below the 52-week high of USD 68.64.
  • Bristol Myers Squibb is scheduled to report third-quarter 2026 results on October 29, 2026.
Bristol Myers Squibb, US1101221083, Illustration mit AI erstellt.
Bristol Myers Squibb, US1101221083, Illustration mit AI erstellt.

Bristol Myers Squibb (ISIN US1101221083) was trading after-hours at EUR 53.13 at Lang & Schwarz on October 8, 2026 at 8:14 p.m. CEST, minus 0.58 percent versus the prior close of EUR 53.44. Its market capitalization was USD 121.5 billion on the same date, the valuation figure that anchors this market report.

Bid and ask frame the price

The Lang & Schwarz bid was EUR 53.03 and the ask was EUR 53.23 on October 8, 2026. The finance quotation showed 4,433,373 shares traded against an average volume of 11,216,521 shares on the same date, putting turnover at 39.51 percent of that average.

Stock stays below its yearly high

On the NYSE, Bristol Myers Squibb was last at USD 59.49 at 2:22 p.m. ET on October 8, 2026. The quotation sat 13.33 percent below the 52-week high of USD 68.64 and 39.91 percent above the 52-week low of USD 42.52.

Valuation remains the key marker

The primary-exchange quotation carried a P/E ratio of 13.10 and a dividend yield of 4.00 percent on October 8, 2026. According to MarketBeat on October 8, 2026, Cantor Fitzgerald cut its target from USD 59.00 to USD 53.00 and kept a neutral rating.

Comparison with peers

Bristol Myers Squibb: minus 0.58 percent, P/E 13.10, market capitalization USD 121.5 billion
Pfizer (NYSE, USD): minus 0.80 percent, P/E 36.69, market capitalization USD 158.3 billion
AbbVie (NYSE, USD): minus 0.35 percent, P/E 76.28, market capitalization USD 477.7 billion

Third-quarter date is set

According to Bristol Myers Squibb in its September 18, 2026 release, the company will report third-quarter 2026 results on October 29, 2026, with its conference call scheduled for 8:00 a.m. ET.

Market value and next date

The combination of a USD 121.5 billion market capitalization, a P/E ratio of 13.10 and a 4.00 percent dividend yield gives the stock report a clear valuation frame. The October 29 reporting date is the next fixed company-specific calendar point.

Price remains the daily anchor

Bristol Myers Squibb was trading at EUR 53.13 after-hours at Lang & Schwarz on October 8, 2026 at 8:14 p.m. CEST, versus the EUR 53.44 prior close dated October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.

Bristol Myers Squibb stock facts

  • Company: Bristol-Myers Squibb Company
  • ISIN: US1101221083
  • Ticker: BMY
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 8, 2026 at 8:14 p.m. CEST): EUR 53.13
  • Change versus prior close: minus 0.58 percent
  • Prior close Lang & Schwarz (October 7, 2026): EUR 53.44
  • Market capitalization: USD 121.5 billion (as of October 8, 2026)
  • 52-week range: USD 42.52-68.64 (as of October 8, 2026)
  • Sector / Industry: Health Care / Biopharmaceuticals
  • Next earnings date: October 29, 2026

Market context: Market report S&P 500.

More news and analyses on Bristol Myers Squibb stock

Disclaimer...

en | US1101221083 | BRISTOL MYERS SQUIBB | boerse | 70269843 | bgmi